83 related articles for article (PubMed ID: 22128267)
61. No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia.
Kohler CG; Martin EA; Kujawski E; Bilker W; Gur RE; Gur RC
Cogn Neuropsychiatry; 2007 Sep; 12(5):412-21. PubMed ID: 17690999
[TBL] [Abstract][Full Text] [Related]
62. Improvement of cognitive impairment following delayed CO encephalopathy.
Song IU; Cho HJ; Kim YD; Chung SW
Can J Neurol Sci; 2011 Nov; 38(6):934-5. PubMed ID: 22030437
[No Abstract] [Full Text] [Related]
63. Cognitive deficits in adult patients with brain tumours.
Taphoorn MJ; Klein M
Lancet Neurol; 2004 Mar; 3(3):159-68. PubMed ID: 14980531
[TBL] [Abstract][Full Text] [Related]
64. Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?
Stiles MM; Martin S; Persons RK
J Fam Pract; 2006 May; 55(5):435-6. PubMed ID: 16670040
[No Abstract] [Full Text] [Related]
65. [Vitamin B1].
Hoshino H
Nihon Rinsho; 2004 Jan; 62 Suppl():361-4. PubMed ID: 15011385
[No Abstract] [Full Text] [Related]
66. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
Harry RD; Zakzanis KK
Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
[TBL] [Abstract][Full Text] [Related]
67. Donepezil in the treatment of vascular dementia.
Ebell MH
Am Fam Physician; 2004 Nov; 70(9):1681-2. PubMed ID: 15554484
[No Abstract] [Full Text] [Related]
68. Neurotoxicity of the CNS: diagnosis, treatment and prevention.
Ricard D; Soussain C; Psimaras D
Rev Neurol (Paris); 2011 Oct; 167(10):737-45. PubMed ID: 21899866
[TBL] [Abstract][Full Text] [Related]
69. Physiopathology of radiation-induced neurotoxicity.
Fike JR
Rev Neurol (Paris); 2011 Oct; 167(10):746-50. PubMed ID: 21889778
[TBL] [Abstract][Full Text] [Related]
70. Management of cognitive deficits and mood disturbance.
Meyers CA
Handb Clin Neurol; 2012; 104():363-9. PubMed ID: 22230454
[No Abstract] [Full Text] [Related]
71. [Neurocognition: Impact of radiotherapy].
Delphine A
Bull Cancer; 2018 Jan; 105(1):126-131. PubMed ID: 29287892
[TBL] [Abstract][Full Text] [Related]
72. Managing the cognitive effects of brain tumor radiation therapy.
Butler JM; Rapp SR; Shaw EG
Curr Treat Options Oncol; 2006 Nov; 7(6):517-23. PubMed ID: 17032563
[TBL] [Abstract][Full Text] [Related]
73. Neurocognitive function in brain tumors.
Correa DD
Curr Neurol Neurosci Rep; 2010 May; 10(3):232-9. PubMed ID: 20425039
[TBL] [Abstract][Full Text] [Related]
74. Complications of radiotherapy to the central nervous system.
Omuro AM; Martin-Duverneuil N; Delattre JY
Handb Clin Neurol; 2012; 105():887-901. PubMed ID: 22230540
[No Abstract] [Full Text] [Related]
75. Intersections between neurobiology and oncology: tumor origin, treatment and repair of treatment-associated damage.
Noble M; Dietrich J
Trends Neurosci; 2002 Feb; 25(2):103-7. PubMed ID: 11814563
[TBL] [Abstract][Full Text] [Related]
76. [Diagnosis and treatment of cognitive deficits caused by radiation in patients with brain tumours].
Ishiuchi S
No Shinkei Geka; 2011 Dec; 39(12):1127-37. PubMed ID: 22128267
[No Abstract] [Full Text] [Related]
77. [Cognitive evaluation during brain radiotherapy in adults: a simple assessment is possible].
Taillia H; Bompaire F; Jacob J; Noël G
Cancer Radiother; 2013 Oct; 17(5-6):413-8. PubMed ID: 24007953
[TBL] [Abstract][Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
